Skip to main content
letter
. 2022 Dec 1;26(12):1188–1190. doi: 10.5588/ijtld.22.0357

Table 1.

Sociodemographic characteristics of study participants.

Variables Level Overall (n = 427) n (%) 8-month treatment regimen (n = 197) n (%) 6-month treatment regimen (n = 230) n (%) P value
Level of health facility Health Centre III 200 (46.8) 83 (42.1) 117 (50.9) 0.088
Health Centre IV 227 (53.2) 114 (57.9) 113 (49.1)
Study sites A 79 (18.5) 26 (13.2) 53 (23.0) 0.01
B 50 (11.7) 34 (17.3) 16 (7.0)
C 112 (26.2) 51 (25.9) 61 (26.5)
D 46 (10.8) 21 (10.7) 25 (10.9)
E 125 (29.3) 58 (29.4) 67 (29.1)
F 15 (3.5) 7 (3.6) 8 (3.5)
Sex Female 123 (28.8) 51 (25.9) 72 (31.3) 0.261
Male 304 (71.2) 146 (74.1) 158 (68.7)
Age groups, years 15–24 65 (15.2) 28 (14.2) 37 (16.1) 0.225
25–34 162 (37.9) 85 (43.1) 77 (33.5)
35–44 121 (28.3) 48 (24.4) 73 (31.7)
45–54 60 (14.1) 29 (14.7) 31 (13.5)
≥55 19 (4.4) 7 (3.6) 12 (5.2)
Mean ± SD 34.6 ± 10.8 34.4 ± 11.0 34.8 ± 10.6 0.695
Risk categories Diabetic patient 1 (0.2) 0 (0.0) 1 (0.4) 0.200
Health worker 1 (0.2) 0 (0.0) 1 (0.4)
Mentally ill 1 (0.2) 0 (0.0) 1 (0.4)
Miner 12 (2.8) 6 (3.0) 6 (2.6)
TB contact 294 (68.9) 126 (64.0) 168 (73.0)
Tobacco user 83 (19.4) 48 (24.4) 35 (15.2)
Uniformed personnel 35 (8.2) 17 (8.6) 18 (7.8)